And here's the white paper for the conference!
friendsofcancerresearch.org/…
1
Optimal Cancer Care Alliance retweeted
Today at 10:00 PM CEST, Dr. Fabio Turco will present the EORTC 2238 “#DeEscalate” #PragmaticTrial
at the 3rd Optimal Cancer Care Alliance Virtual Meeting.
👉optimalcancercare.org/
@OCCA_Cancer @UChicago #CancerResearch #ClinicalTrials #Oncology
Optimal Cancer Care Alliance retweeted
Today at 10:35 PM CEST, Our CEO, Dr. Denis Lacombe, will discuss the EMA #CancerMedicinesForum at the 3rd Optimal Cancer Care Alliance Virtual Meeting.
👉optimalcancercare.org/
@OCCA_Cancer @UChicago #CancerResearch #ClinicalTrials #Oncology
New work from OCCA Board Member Mark Ratain @UCCancerCenter in @statnews statnews.com/2023/08/15/nih-…
1
101
Optimal Cancer Care Alliance retweeted
This is going to be excellent meeting . All are encouraged to register and attend . @OCCA_Cancer
Optimal Cancer Care Alliance retweeted
Important meeting announcement. Optimal dosing of Anticancer drugs . @OCCA_Cancer @ian_tannock @tmhmedoncalumni @ISMPOofficial @IJMPOofficial
Optimal Cancer Care Alliance retweeted
Efforts to stop ✋ Merc from applying for patent extension for SUBCUT pembrolizumab. Letter by USA 🇺🇸 senetors and congress members @SenWarren @BernieSanders @RepKatiePorter @RepJayapal . Such efforts 👌👏 will hopefully help to get more access to pembrolizumab across the 🌎
Optimal Cancer Care Alliance retweeted
Ignore at your own risk: FDA draft guidance puts flashing lights around “dose optimization.” Guest editorial by Mark Ratain and @garthstrohbehn (@CancerOptimal).
cancerletter.com/trials-and-…
Optimal Cancer Care Alliance retweeted
Very Happy 🎉🎉 to share that low dose immunotherapy full text is published in JCO. @JCO_ASCO @VanitaNoronha @Nandinimenon18 @Amolpatel_dr @SuyogCancer @tmhmedoncalumni @oncology_bg Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study . ascopubs.org/doi/abs/10.1200…
Optimal Cancer Care Alliance retweeted
This article summarises ongoing immune checkpoint inhibitor optimisation trials. Establishing optimised immune checkpoint inhibitor protocols will be challenging, but is a necessary step toward global access. @OCCA_Cancer @MRCCTU nature.com/articles/s41591-0…
Optimal Cancer Care Alliance retweeted
Please join us in reading out latest publication in @NatureMedicine, discussing dose optimization for ICI to allow global access.
Thank you to all the co-authors for their guidance: Dr. Gilbert, @MarcusButler_PM, @drdgoldstein and Dr. Tannock
nature.com/articles/s41591-0…
Optimal Cancer Care Alliance retweeted
.@OCCA_Cancer: "It is highly likely that CodeBreak 201 will show that the therapeutic index of sotorasib 240mg daily is superior to that of sotorasib 960 mg daily. Given this probable result, we suggest that the FDA should not grant full approval."
cancerletter.com/guest-edito…
Optimal Cancer Care Alliance retweeted
Data presented at ESMO strengthens concern that the labeled dose of sotorasib is not optimal. Guest editorial by @OCCA_Cancer's Mark Ratain (@UCCancerCenter), @garthstrohbehn (@UMRogelCancer), Ian Tannock (@pmcancercentre), & Allen Lichter (@CancerOptimal)
cancerletter.com/guest-edito…
Optimal Cancer Care Alliance retweeted
Interventional Pharmacoeconomics . Excellent points made by @ian_tannock @SirohiBhawna @oncology_bg #choosingwisely22 @ecancer @OCCA_Cancer
For those at #ESMO22 Paris - Please join us Friday 9 Sept from 18:30-21:30 for the @OCCA_Cancer / @MRCCTU Optimising Cancer Care Update. A great evening of talks, discussion, and buffet in store. 1/2
For registration or for more details, please DM @OCCA_Cancer or @drdgoldstein 2/2
1
More @OCCA_Cancer action on Capitol Hill - from @US_FDA Appropriations Bill for 2023… 1/
1
2
“The Committee strongly encourages FDA to organize clinical trials…of marketed cancer drugs and biologics to assess whether dosing and frequency adjustments may decrease the cost of care and/or toxicities of treatment without compromising efficacy.” 4/
Lots of research and advocacy on behalf of patients in the US by @OCCA_Cancer, @FDAOncology, and @CancerResrch has gotten us here. Making this vision a reality will require continued efforts globally! We’re excited to get to work. 5/
2



















